Taken together the above discussion, we hypothesized that the “double braking” effects of CsA binding with CypD and siRNA downregulating MCU expression on mPTP opening would synergistically inhibit the release of DAMPs, thereby suppressing the EMT process and attenuating the progression of IPF. The gene discussed is MCU; the disease is idiopathic pulmonary fibrosis.